Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Gut microbiota and health, Microscopic Colitis, and Autoimmune and Inflammatory Disorders.
The Serine Protease-Serine Protease Inhibitor Regulatory Network in Inflammatory Bowel Disease: From Molecular Mechanisms to Novel Therapeutic Horizons.
Mesenchymal stem cell-derived exosomes derived from induced pluripotent stem cells ameliorate inflammation and promote mucosal healing via miR-34a-5p in Crohn disease.
Shifting burden of inflammatory bowel disease in women of childbearing age: from high-income to low-income countries (1990-2021).
Magnetic resonance enterography for predicting poor prognosis in Crohn's disease: a systematic review with meta-analysis.
Early Improvement of Mental Health Is Associated With Long-Term Disease Remission in Ulcerative Colitis.
Therapeutic potential of the secreted Kazal-type serine protease inhibitor SPINK4 in colitis
Stanniocalcin-1 Promotes PARP1-Dependent Cell Death via JNK Activation in Colitis.
Bacteroides uniformis ameliorates pro-inflammatory diet-exacerbated colitis by targeting endoplasmic reticulum stress-mediated ferroptosis
Therapeutic potential of the secreted Kazal-type serine protease inhibitor SPINK4 in colitis.
Predictors for colectomy in patients with acute severe ulcerative colitis: a systematic review and meta-analysis.
Rapidly achieving clinical remission in ulcerative colitis indicates better endoscopic and histological outcomes.
Platelet-to-lymphocyte percentage ratio for assessing disease activity and predicting therapeutic outcomes in ulcerative colitis.
Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn’s disease: a multi-omics Mendelian randomization study
Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn's disease: a multi-omics Mendelian randomization study.
Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis
Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets
Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis: A Randomized Clinical Trial.
Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets.
Serum amyloid protein A in inflammatory bowel disease: from bench to bedside
Serum amyloid protein A in inflammatory bowel disease: from bench to bedside.
Dietary palmitoleic acid reprograms gut microbiota and improves biological therapy against colitis.
Recent developments on BMPs and their antagonists in inflammatory bowel diseases
Recent developments on BMPs and their antagonists in inflammatory bowel diseases.
Protocadherin 20 maintains intestinal barrier function to protect against Crohn's disease by targeting ATF6.
Role of Rho GTPases in inflammatory bowel disease.
Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease.
Neutrophil-to-lymphocyte ratio for predicting postoperative recurrence in Crohn's disease patients with isolated anastomotic lesions.
Fecal lactoferrin early predicts long-term outcomes in ulcerative colitis: A post-hoc analysis of the UNIFI and PURSUIT trials.
A Novel Nomogram Combining Mucus Barrier Index for Predicting Treatment Failures in Ulcerative Colitis.
Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation